Interceptor effect of C₆₀ fullerene on the in vitro action of aromatic drug molecules by Skamrova, G. B. et al.
Interceptor effect of C60 fullerene on the in vitro action 
of aromatic drug molecules
Galyna B. Skamrova • Ivan Laponogov • Anatoly S. Buchelnikov • 
Yuriy G. Shckorbatov • Svitlana V. Prylutska • Uwe Ritter •
Yuriy I. Prylutskyy • Maxim P. Evstigneev
Received: 2 October 2013 / Revised: 20 March 2014 / Accepted: 1 April 2014 
© European Biophysical Societies’ Association 2014
Abstract C60 fullerenes are spherical molecules com­
posed purely of carbon atoms. They inspire a particularly 
strong scientific interest because of their specific physico­
chemical properties and potential medical and nanotech­
nological applications. In this work we are focusing on 
studying the influence of the pristine C60 fullerene on bio­
logical activity of some aromatic drug molecules in human 
buccal epithelial cells. Assessment of the heterochromatin 
structure in the cell nucleus as well as the barrier function 
of the cell membrane was performed. The methods of cell 
microelectrophoresis and atomic force microscopy were 
also applied. A concentration-dependent restoration of the 
functional activity of the cellular nucleus after exposure to 
DNA-binding drugs (doxorubicin, proflavine and ethidium 
bromide) has been observed in human buccal epithelial 
cells upon addition of C60 fullerene at a concentration of 
-1СГ5 M. The results were shown to follow the framework
of interceptor/protector action theory, assuming that non- 
covalent complexation between C60 fullerene and the drugs 
(i.e., hetero-association) is the major process responsible 
for the observed biological effects. An independent con­
firmation of this hypothesis was obtained via investigation 
of the cellular response of buccal epithelium to the coad­
ministration of the aromatic drugs and caffeine, and it is 
based on the well-established role of hetero-association in 
drug-caffeine systems. The results indicate that C60 fuller­
ene may reverse the effects caused by the aromatic drugs, 
thereby pointing out the potential possibility of the use of 
aromatic drugs in combination with C60 fullerene for regu­
lation of their medico-biological action.
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Introduction
In recent years, there has been a rapid growth of interest in 
the physico-chemical properties of pristine C6fl fullerenes 
due to their extensive application in medicine and nanobi­
otechnology (Anilkumar et al. 2011; Cataldo and Da Ros 
2008). It has been shown previously that C6fl fullerene is 
able to penetrate through the cell membrane (Foley et al. 
2002; Prylutska et al. 2012; Qiao et al. 2007) and exhib­
its antioxidant properties (Prylutska et al. 2008). Being 
non-toxic, at least at low concentrations (Andrievsky et al. 
2005; Aschberger et al. 2010; Kolosnjaj et al. 2007; Prylut­
ska et al. 2007a), pristine C6fl fullerenes are able to suppress 
the growth of malignant tumors (Prylutska et al. 2011a, b).
Recently, it was found that the in vivo application of 
pristine C6fl fullerene together with the DNA-binding anti­
cancer drug doxorubicin results in enhancement of the bio­
medical effect of the latter (Prylutska et al. 2011c). This 
result creates a scientific basis for the new technology of 
C6fl fullerene application in anticancer therapy based on 
simultaneous administration of an anticancer drug and a 
C6fl fullerene. Taking into account that C6fl fullerene has a 
saturated 7r-electron system and therefore can form com­
plexes with aromatic DNA intercalators, including antineo­
plastic antibiotics and mutagens (Buchelnikov et al. 2013; 
Evstigneev et al. 2013; Mchedlov-Petrossyan et al. 2001), 
it was suggested that a non-covalent complexation in the 
'drug-fullerene' system (also referred to as hetero-associ- 
ation) is a key mechanism causing the observed biological 
synergism (Evstigneev et al. 2013). It has been known for 
quite a long time and so far been observed in proliferat­
ing cells or bacterial systems [see for review (Evstigneev 
et al. 2008; Evstigneev 2010, 2013)] that hetero-association 
regulates the action of the biologically active compounds 
during simultaneous administration of combinations of dif­
ferent aromatic molecules, one of which is the main drug of 
interest, and the other one is an interceptor molecule. This 
phenomenon is referred to as an 'interceptor' mechanism. 
However, the study of such a mechanism is complicated by 
possible influence from other molecular processes, one of 
which is most often referred to as a 'protector' mechanism,
i.e., the drug/interceptor competition for the binding sites 
on DNA (Buchelnikov et al. 2012; Evstigneev 2010, 2013; 
Evstigneev et al. 2011; Goluriski et al. 2013). Investigation 
of the interceptor and protector mechanisms for DNA-bind­
ing drugs used in combination is the subject of the theory 
of interceptor/protector action (Buchelnikov et al. 2012; 
Evstigneev et al. 2008, 2011; Evstigneev 2010). Unfortu­
nately, the applicability of the protector mechanism within 
the system containing C6fl fullerene cannot be estimated 
on the basis of the currently available literature data. This 
is because the characteristics of the C6fl fullerene binding 
with DNA under conditions close to the physiological ones
are unknown except for the data reported in the theoretical 
work (Zhao et al. 2005), which has not yet received experi­
mental confirmation.
In the present work, human buccal epithelial cells were 
used as a biological test system in order to investigate the 
possible role of the interceptor mechanism in regulation 
of the biological activity of DNA-binding aromatic com­
pounds (referred to as BACs for 'biologically active com­
pounds') in the presence of C6fl fullerene. The relatively 
large size of these cells allows one to observe the structural 
changes in nuclear chromatin and the state of the cellu­
lar membranes using a simple biological microscope and 
with minimal intervention into the system while maintain­
ing good reproducibility of the results (Shckorbatov et al. 
2009a, b). In addition, buccal epithelial cells are non-pro­
liferating and, to the best of our knowledge, the studies of 
the combined effects of aromatic drugs have been reported 
only for proliferating cell systems so far (see above). 
Assuming that C6fl fullerene acts via the interceptor mecha­
nism, the observed effects should not depend on the type 
of cellular system used. Hence, the general features of its 
manifestations should be similar in proliferating and non­
proliferating cell cultures, and buccal epithelial cells may 
serve as a good test system to verify the hypothesis about 
the role of the interceptor mechanism in the regulation of 
biological activity of DNA-binding BACs.
A range of typical DNA-binding aromatic BACs has 
been used in the present study: the antitumor antibiotic 
doxorubicin (DOX), aromatic mutagen proflavine (PF) and 
ethidium bromide (EB). These drugs form stable non-cova­
lent complexes with C6fl fullerene (Buchelnikov et al. 2013; 
Evstigneev et al. 2013) and were previously characterized 
as the ligands that follow the mechanism of interceptor/ 
protector action when used in combination with various 
types of aromatic interceptor molecules (Buchelnikov et al. 
2012; Evstigneev et al. 2006, 2008; Evstigneev 2010, 2013; 
Larsen et al. 1996; Piosik et al. 2010; Traganos et al. 1991).
Materials and methods
Epithelial cells
Human buccal epithelial cells were collected from three 
adult donors with a sterile obtuse spatula and washed three 
times by centrifugation (2 min at 3,000 rpm) in a phosphate 
buffer of the following composition: 3.03 mM phosphate 
buffer (pH 7.0) with addition of 2.89 mM calcium chloride. 
Cells were then diluted with the same buffer solution (further 
referred to simply as 'buffer solution') to a concentration of 
1-2 x 105 cells per ml, as determined by microscopic count, 
and 0.5-ml aliquots were pipetted into the Eppendorf tubes. 
During the course of the experiment, no visible changes in
the structure of the nucleus and cell membrane, or in the cell 
nuclei electronegativity and chromatin state in the investi­
gated cells were observed in the control group.
Compounds
C6fl fullerene: The pristine C6fl fullerene aqueous colloidal 
solution (C6flFAS) used for the experiments was prepared 
as follows (Prylutska et al. 2007b; Scharff et al. 2004): a 
saturated solution of C6fl fullerene (purity 99.5 %) in tolu­
ene was mixed with the same amount of distilled water, and 
the resulting two-phase system was ultra-sonicated until 
the toluene had completely evaporated. Following this, the 
yellow-colored water phase was filtered to remove undis­
solved C6fl fullerene. A C6flFAS sample with a maximum 
concentration of C6fl fullerene in water of 0.1 mg ml-1 
(1.39 x 10-4 M) was prepared.
The state of C6fl fullerene was monitored using atomic 
force microscopy (AFM; “Solver Pro M" system; NT-MDT, 
Russia). The sample was deposited onto a cleaved mica 
substrate (V-l grade, SPI supplies) by precipitation from an 
aqueous solution droplet. Sample visualization was carried 
out in semi-contact (tapping) mode after complete evapora­
tion of the solvent. NSG10 (NT-MDT) probes were used. The 
AFM picture (Fig. 1) clearly demonstrates the presence of 
single C6fl molecules in water, as well as their clusters with a 
typical 2-100-nm range of diameters, which is in agreement 
with theoretical calculations (Bulavin et al. 2000; Prylutskyy 
et al. 1999, 2001), a small-angle neutron (Scharff et al. 2004) 
and dynamic light scattering (Prylutskyy et al. 2013) data.
Doxorubicin (DOX)
A stock solution of DOX (Doxoribicin Teva, The Nether­
lands) with a concentration of 2 mg ml-1 (3.448 x 10 M) 
was prepared by dissolving the compound (10 mg) in 5 ml 
of buffer solution. The initial stock solution (0.058 ml) was 
used to obtain a final working solution (2 x 10 4 M) by 
addition of 0.942 ml of buffer solution.
Ethidium bromide (EB)
A stock solution of EB (Sigma, USA) with a concentration 
of 1 x 10 M was prepared by dissolving the compound 
(1.97 mg) in 5 ml of buffer solution. The initial stock solu­
tion (0.4 ml) was used to obtain the final working solution 
(4 x 10~4 M) by addition of 0.6 ml of buffer solution.
Proflavine (PF)
A stock solution of PF (Sigma, USA) with a concentration 
of 1 x 10 ' M was prepared by dissolving the compound 
(1.05 mg) in 5 ml of buffer solution. The initial stock
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Fig. 1 The AFM image of the distribution of C60 fullerenes in water 
at a concentration of 0.1 mg ml-1
solution (0.4 ml) was used to obtain the final working solu­
tion (4 x 10~4 M) by addition of 0.6 ml of buffer solution.
Caffeine (CAF)
A stock solution of CAF (Sigma, USA) with a concentra­
tion of 1 x 10 2 M was prepared by dissolving the com­
pound (9.71 mg) in 5 ml of buffer solution.
Chromatin state evaluation
The change in functional state of the cell nucleus is cor­
related with the structural transitions from heterochromatin 
to euchromatin. An increase in the quantity of heterochro­
matin granules (HGQ) indicates a decrease in the transcrip­
tional activity of the nucleus. The evaluation of the HGQ 
parameter was performed using the method described in 
detail in (Shckorbatov et al. 2009b). Exposed cells and the 
control sample were stained with 2 % solution of indigo 
carmine in 45 % acetic acid. Cell nuclei were visually 
examined under the MICROmed XS-3330 microscope 
using l,000x magnification (Fig. 2a). In each sample, the 
HGQ parameter was determined for 30 randomly selected 
cells. It was shown previously (Shckorbatov et al. 2009b) 
that this number is optimal, i.e., a further increase in the 
number of analyzed cells does not result in a significant 
decrease of standard error; however, it remarkably slows 
down the whole analysis. The person investigating the 
HGQ was 'blind' to the exposure conditions, and all meas­
urements were made by the same person.
Membrane state evaluation
The state of the cell membranes was assessed by measuring 
the percentage of cells stained in vitro by indigo carmine
Fig. 2 Images o f human buccal 
epithelial cells: a evaluation of 
the heterochromatin gran­
ule quantity [cell nucleus, a 
control sample (left), a sample 
incubated with one o f the drugs 
{right)]; b evaluation of cell 
membrane permeability [cells 
not stained {left) and stained 
{right) with indigo carmine]; 
с evaluation of the cell nuclei 
electronegativity [nuclei shift­
ing, anode on the left hand side 
{top), anode on the right hand 
side {bottom)]
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(5 mM solution for 5 min) (an example of stained cells is 
given in Fig. 2b) (Shckorbatov et al. 1995). As a control, 
when human cells were exposed to detergent solutions 
known to disrupt cell membrane integrity (Triton X-100, 
Escin), the percentage of stained cells (PSC, %) increased 
considerably, indicating a direct correlation of this parame­
ter with membrane permeability (Shckorbatov et al. 1995). 
In the PSC method 300 cells (3 repeats, 100 cells each) in 
each experiment were examined. Counting of the stained 
cells was performed under the MICROmed XS-3330 
microscope with 400 x magnification by a person ‘blind’ to 
the exposure conditions.
Evaluation of the electronegativity of the nuclei
Assessment of the nuclei electronegativity (ENN, %) was 
performed using the method described in Shckorbatov 
et al. (2002). Human buccal epithelial cells were placed in 
the microelectrophoresis unit between two coverslips. The 
microelectrophoresis unit was then filled with the buffer 
solution and affixed to the microscope stage. The stud­
ies were performed using electric fields of 10-12 V cm-1, 
electric currents of 0.2-0.4 mA and a fixed frequency of
0.1 Hz. The snapshots of the sample were taken during the 
experiment (at positive and negative voltage peaks) using 
a CCD camera. Figure 2c illustrates movement of individ­
ual nuclei influenced by changes in electrode polarity. The 
nuclei inside buccal epithelial cells exhibited either a nega­
tive charge and moved toward the anode or did not shift in 
the electric field, thereby not bearing electric charge under 
these experimental conditions and sensitivity threshold. 
The ENN quantity was defined as the percentage of cells
with negatively charged nuclei (i.e., shifting in the electric 
field). For each sample, three ENN measurements were 
made with 100 nuclei analyzed per measurement, and then 
the mean value was evaluated.
Determination of changes in drug toxicity in the presence 
of C6fl fullerene
Then 0.05 ml drug solution and 0.95 ml C6flFAS were 
mixed (received 1 x 10 5 M of DOX or 2 x 10 5 M of 
EB or PF solutions with 1.32 x 10 4 M of C6fl fullerene). 
To obtain the titration solution, 0.2 ml of the drug solu­
tions with 3.8 ml of buffer solution were mixed (received 
1 x 10 5 M of DOX or 2 x 10 5 M of EB or PF solutions). 
The drug-fullerene mixture with different fullerene concen­
trations was added to the cell suspension (0.5 +  0.5 ml; the 
initial concentration of C6fl fullerene was 6.6 x 10 5 M). 
The cells were then incubated in the prepared solutions for 
1 h. The cells that were incubated only in the drug solutions 
without C6fl fullerene added were considered the ‘positive 
control;’ the cells incubated without the drugs and fullerene 
were considered the ‘negative control.’ The changes in the 
HGQ and ENN parameters in comparison to the controls 
were investigated for three donors separately. The incuba­
tion of the cells was performed at 36 ±  1 °C. The negative 
control sample was kept at the same temperature.
Statistical analysis
All computations of the mean values and standard errors 
were made in Microsoft Office Excel and SigmaPlot. The 
statistical significance of all observed differences between
the means of obtained data and control values was evalu­
ated using Student's t test. The confidence level was taken 
as p < 0.05.
Results and discussion
The biological activity of the selected DNA-binding aro­
matic drugs in human buccal epithelial cells was evaluated 
using three different quantitative parameters, i.e., HGQ, 
which reflects possible changes in the state of cell chro­
matin; PSC, assessing the state of the cellular membrane; 
ENN, defined by the electrokinetic properties of cell nuclei.
Individual action of the drugs
The first stage of the experiment was designed to investi­
gate the individual action of each of the tested drugs, i.e., 
DOX, EB, PF, and C6fl fullerene, on buccal epithelial cells 
in order to determine the optimal concentrations and expo­
sure times for the further study of these compounds in 
combination. Assessment of the electrokinetic properties 
of nuclei and the chromatin state as well as the cell mem­
brane permeability was carried out based on the changes 
in ENN, HGQ and PSC relative to the control sample as a 
function of the concentration of the compound of interest. 
The exposure time for the cell culture in the presence of the 
drugs varies from 10 min to 3 h, and the drug concentration 
ranges from 10 x to 10 5 M. The obtained results are pre­
sented in the Supplementary materials (tables with experi­
mental data and Student's t-test results) as well as Fig. 3.
Analysis of the individual influence of DOX, EB and 
PF shows that the PSC percentage for each sample remains 
constant within the range of statistically meaningful differ­
ences for all the concentrations and exposure times studied 
for all donors. Consequently, none of these drugs affects the 
barrier function of the cell membrane, and the PSC param­
eter can be excluded from further investigations. How­
ever, the changes in the structure of heterochromatin (the 
HGQ parameter) and the nuclei electronegativity (the ENN 
parameter) are apparent. It is considered that the process of 
chromatin condensation (heterochromatinization) leads to a 
decrease in the DNA availability for the different enzymes 
that play regulatory roles in the process of transcription 
(Martin and Cardoso 2010). It was found that at concentra­
tions of up to 0.01 mM and exposure times from 10 min to 
3 h, the general pattern of DOX, EB and PF impacts on the 
chromatin state, and the nuclei electronegativity of buccal 
epithelial cells was generally similar. In particular, the data 
in Fig. 3 demonstrate the increase in the HGQ parameter 
after 10 min with DOX exposure, whereas the decrease in 
the ENN parameter was observed for the highest concentra­
tion only (i.e., at 5 x 10 6 M). Incubation with EB and PF
also results in an HGQ increase for all drug concentrations 
after 1 h of exposure, but the changes in the ENN param­
eter in this case occur only at 1 x 10 5 M concentration.
It should be noted that the mechanism of biological 
action of aromatic BACs, such as DOX, EB and PF, may 
also be viewed in terms of other processes such as enzyme 
inhibition, direct membrane action or generation of ROS 
(for reviews, see Evstigneev 2010; Evstigneev et al. 2013). 
The studied drugs are similar in their ability to intercalate 
into DNA, but are very different in their ability to generate 
ROS or bind with enzymes or membranes. The fact that all 
of the studied drugs have demonstrated an apparent influ­
ence on the state of the chromatin and a negligible effect on 
the state of the cellular membrane suggests that the primary 
mode of the drug action in human buccal epithelial cells is 
likely to be through binding with DNA.
The obtained data allow choosing the optimal conditions 
for subsequent experiments in the presence of C6fl fuller­
ene, i.e., the concentrations of 5 x 10 6 M for DOX and 
1 x 10 5 M for EB and PF, and the exposure time equal to 
1 h. The selected concentrations correspond to the maximal 
changes of the HGQ and ENN parameters observed within 
1 h of exposure and with no significant further changes 
after 1 h.
Investigation of the effect of C6fl fullerene on buccal epi­
thelial cells (see Supplementary material, Table 4) showed 
no statistically meaningful changes in any of the three 
parameters for all the concentrations and donors studied. 
This suggests that C6fl fullerene by itself does not exhibit 
any noticeable damaging effect on the cell membrane or 
nucleus under these experimental conditions. These results 
agree with the widespread opinion that pristine C6fl fuller­
ene is non-toxic (Andrievsky et al. 2005).
In summary, based on the results of the preliminary 
experimental stage, it can be concluded that:
1. The effect of the test compounds DOX, EB and PF 
is exerted at the cell nucleus and chromatin level, but 
not at the membrane level. Indirectly, this indicates a 
DNA-dependent mechanism of action of these drugs 
on the functional state of the cell. Also the results 
obtained allow further exclusion of the membrane per­
meability test as a measure of the biological effects of 
the test drugs in the presence of C6fl fullerene.
2. The effect of C6fl fullerene is observed neither at the 
nucleus level nor at the level of the membrane. First, 
it allows neglecting the effect of C6fl fullerene on the 
cell's functional state from the measurements of the 
HGQ and ENN parameters in the subsequent study 
of joint action of the drugs and fullerene. Second, 
it indirectly indicates the absence of an apparent cell 
response from possible C6fl fullerene binding to DNA, 
hence the possibility, in a first approximation, to
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Fig. 3 Changes in the HGQ, ENN and PSC parameters upon expo­
sure to the test compounds: DOX, EB, PF, C60 fullerene and CAF 
(mean values ±  standard error; asterisk statistically meaningful val­
ues with respect to the control; the legend contains the concentrations 
of the compounds)
exclude the protector mechanism (see the introductory 
section) from the analysis.
Drug action in the presence of C6fl fullerene
The results of the experiments for each combination of 
compounds, viz. DOX-C6fl, EB-C6fl and PF-C6fl, are shown 
in Fig. 4 (as an example for one donor) and also in the Sup­
plementary material (Tables 6-8).
The most important result that comes from the analy­
sis of the obtained data is the apparent reaction of the cell 
nucleus to the additional presence of C6fl fullerene in the 
system. As in the case of individual action of the drugs, 
the changes in the measured parameters in the presence of 
fullerene are qualitatively similar for different drugs and 
donors. It was established that for each drug a decrease in 
the HGQ parameter from the positive control level down 
to the negative control level takes place upon the increase 
of the C6fl fullerene concentration, indicating the restora­
tion of the nucleus functional activity by the administra­
tion of the C6fl molecule. The range of the HGQ parameter 
variation is, on average, two times higher than that for the 
ENN parameter, indicating higher sensitivity of the hetero­
chromatin restructuring factor as compared with the nuclei 
electronegativity.
It was also found that the ENN parameter features a 
high negative correlation (in the range of r ~  —0.8...—0.9) 
with the HGQ parameter in all performed experiments. 
The existence of such a relationship between the chromatin 
state in the nucleus and the nuclei electronegativity for buc­
cal epithelial cells was also reported previously (Shckorba­
tov et al. 1998), implying the unified nature of the observed 
effects caused by the combinations of the compounds stud­
ied. Our results show that this is not a donor-dependent 
result.
In the context of the revealed biological synergism in the 
drug-fullerene systems, we would like to bring attention to 
the following two issues:
1. The existence of the pronounced dependence of the 
effects caused by the tested drugs on the C6fl fullerene 
concentration (Fig. 4), resulting ultimately in the resto­
ration of the cell system to its initial state;
2. The recently discovered ability of C6fl fullerene to form 
stable heterocomplexes with these compounds (Evs­
tigneev et al. 2013).
These features enable us to draw a parallel with the 
well-investigated drug-xanthine systems (Buchelnikov 
et al. 2012; Evstigneev et al. 2006, 2008, 2011; Evstign­
eev 2010, 2013; Goluriski et al. 2013; Larsen et al. 1996; 
Piosik et al. 2010; Traganos et al. 1991; Woziwodzka 
et al. 2011), for which similar effects are observed on
joint in vitro action of aromatic BACs. Of particular 
importance here is that in the drug-xanthine systems, the 
operation of the interceptor mechanism (i.e., the drug- 
xanthine hetero-association) can be considered as widely 
accepted. Also taking into account that no apparent 
C6fl binding with DNA has been reported so far (see the 
introductory section) and the non-responsiveness of buc­
cal epithelial cells to the addition of C6fl to the medium 
observed in our experiments, it is possible to propose that 
the effects observed in the drug-fullerene systems are 
mainly described by the interceptor mechanism, while the 
role of the protector mechanism is negligible. Let us fur­
ther develop this view.
The published values of the equilibrium constants of 
hetero-association, Kh, measured under identical experi­
mental conditions for the drug-fullerene and drug-xanthine 
systems are shown in Table 1. As a typical representative of 
xanthines and the most well-studied interceptor molecule, 
caffeine was chosen. The Kh value for the EB-C6fl system is 
absent in the literature; therefore, in the subsequent calcula­
tions, the intermediate value between DOX-C6fl and PF-C6fl 
constants was used. The reason for this is a significant role 
of the amino sugar in the structure of the DOX molecule 
revealed in Evstigneev et al. (2013), which envelopes the 
surface of C6fl fullerene and enhances Kh because of the 
favorable hydrophobic and van der Waals interactions. A 
similar effect can be expected in the EB molecule as well 
due to the presence of the phenolic ring, although it has 
smaller dimensions.
Inspection of the data in Table 1 suggests that the Kh 
values for the drug-fullerene systems are at least two 
orders of magnitude higher than the equivalent values 
in the drug-xanthine ones, giving the reason to expect a 
more substantial contribution of the interceptor mecha­
nism in these systems as compared with the xanthine- 
containing ones. Unfortunately, identification of the role 
of the interceptor mechanism directly at the cellular level 
is not possible, and in similar works available in the lit­
erature, the conclusions about its significance are com­
monly made on the basis of either the fact of an effective 
drug-interceptor hetero-association (Piosik et al. 2010; 
Traganos et al. 1991; Woziwodzka et al. 2011), or the 
ability to describe in vitro data within the framework of 
the theory of interceptor/protector action (Buchelnikov 
et al. 2012; Evstigneev et al. 2008, 2011; Evstigneev 
2010). The existence of an effective hetero-association 
in the drug-fullerene systems has been shown previously 
(Evstigneev et al. 2013), and the degree of correspond­
ence of the parameters measured in the present work 
(HGQ, ENN) with the theory of interceptor/protector 
action was investigated in order to gain further under­
standing of the role of the interceptor mechanism in the 
biological effects observed (see Fig. 4).
Fig. 4 Changes in the HGQ 
and ENN parameters upon 
exposure to the drugs in the 
presence o f C60 fullerene (mean 
values ±  standard error; asterisk 
statistically meaningful values 
with respect to the control; the 
legend contains the concentra­
tions o f C60 fullerene)
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Table 1 Equilibrium constants o f hetero-association (.K ,^ M *)
DOX EB PF
C60 fullerene (Evstigneev et al. 2013) 61,900 44,000* 26,100
CAF (Evstigneev et al. 2008) 208 62 160
* See the explanation in the text
Testing the correspondence of the experimental data to the 
theory of interceptor/protector action
As a working hypothesis, it was assumed that the inter­
ceptor mechanism plays the major role in causing the 
effects on the chromatin state in buccal epithelial cells
in drug-fullerene systems (see Fig. 4). It was also taken 
into consideration that the drug-fullerene hetero-associ- 
ation induces an additional aggregation of C6fl fullerene 
in solution (Evstigneev et al. 2013). Hence, the concen­
trations of the monomer and the low molecular weight 
aggregates of C6fl fullerene in solution can be neglected 
in a first approximation. Consequently, in a particular 
case of operation of only the interceptor mechanism in 
buccal epithelial cells, the theory of interceptor/protec­
tor action must predict the concentration dependencies 
of the measured parameters close to the experimental 
ones (see Fig. 4). The approximate equation that can 
describe the experimental data shown in Fig. 4 is pre­
sented below.
The theory of interceptor/protector action (Buchel­
nikov et al. 2012; Evstigneev et al. 2006, 2008, 2011; Evs­
tigneev 2010) uses the system of mass balance equations 
in the drug-interceptor-DNA system in order to compute 
the AD factor, which is proportional to the amount of the 
drug X  displaced from the DNA because of the introduc­
tion of the interceptor Y, /(A’(li —/<?, relative to the frac­
tion of X-DNA complexes in the absence of Y, /(A’(li (i.e., 
at Къ =  0)
Ad = /c(0) ~ /c
fc{0)
( 1 )
where the mole fraction, fS , is defined as f x  = KxnxiNi ■9 J С ’ J XQ
KXN is the equilibrium constant of complexation of X  with 
DNA; X, and x(l are the concentration of monomer X  and 
the total concentration of X, respectively; /V, and N (] are the 
concentration of the free X-binding sites on DNA and the 
total concentration of the X-binding sites, respectively.
It is assumed that the AD factor is proportional to the 
change in a biological parameter measured in vitro relative 
to the control value (in our case, these are the HGQ or ENN 
parameters) (Buchelnikov et al. 2012; Evstigneev et al. 
2006, 2008, 2011; Evstigneev 2010). Once the magnitudes 
of X, and /V, are known from the solution of the system 
of mass balance equations, the value of AD can be further 
computed and compared against the experimental data. The 
system of mass balance equations, assuming the absence 
of the protector mechanism (i.e., the Y binding with DNA), 
potentially low concentrations of the free drug, x 1 (i.e., not 
bound to DNA or fullerene) and 1:1 stoichiometry of X -Y  
hetero-association, is given by
Xo =  X i  +  К ЪХ1У1 +  K x n X i N i  
У о =  У1 +  K hx i y i  
N o  =  N i +  K x n x i N i
(2)
where Vj corresponds to the concentration of the free (not 
bound with the drug) and yn is the total amount of C6fl 
fullerene.
It is known that the total concentration, N (l, of the avail­
able binding sites on DNA is relatively low [about 10 6-  
10-5 M, see (Evstigneev et al. 2008, 2011)], whereas the 
concentration of C6fl fullerene, yfl, used in experiments is 
higher (about 10 5—10 4 M). At the same time, the affini­
ties of the drugs to DNA and to C6fl fullerene are compara­
ble by an order of magnitude, viz. Kh ~ KXN ~ 104— 105 M 1 
(Evstigneev et al. 2008, 2013). This implies that a signifi­
cantly greater portion of the drug X  forms complexes with 
C6fl fullerene in comparison with the fraction of X-DNA 
complexes; hence, the Kxnx1N 1 term in Eq. (2) can, in a 
first approximation, be neglected. In addition, the con­
centrations of the drugs used in the experiments are suffi­
ciently small (xfl ~ 10 6- l0  5 M); thus, Khx t < <1. The set
of these assumptions allows us to reduce the system in Eq. 
(2) to the form:
No ~  N i, xi
xo
1 +  K\{y i У о  « V I .
Taking Eq. (1) further into account, an approximate 
expression for the theoretically predicted magnitude of the 
AD factor can be written in the form:
Ad
h^VQ 
1 +  -К11УО (3)
Estimation of the experimental AD factor can be per­
formed following the approach suggested in Evstigneev 
et al. (2008, 2011), i.e., by measuring the changes in the 
biological parameters in the presence of C6fl fullerene rela­
tive to the values of the same parameters in the absence of 
the fullerene for the same drug concentrations. Since the 
HGQ parameter was shown to be the most sensitive to any 
changes in the functional state of the cell (see above), only 
this parameter was used for the AD factor evaluation (see 
Supplementary material) according to the formula
Ad =
A 'c-A 'p
No T  _  Nc - N i
A'c-A'p
No
N c - N o ’ (4)
where N c and No are the magnitudes of the HGQ parameter 
in the positive and negative controls, respectively; /V, is the 
magnitude of the HGQ parameter for the given drug and 
C6fl fullerene concentrations.
Figure 5 presents experimental [re-calculated using Eq. 
(4)] and theoretical [calculated according to Eq. (3)] values 
of the Ad factor. The results show a reasonably good repro­
duction of the experimental data when the set of assump­
tions introduced above within the framework of the theory 
of interceptor/protector action is used, being especially 
good for the DOX-C6fl system (R2 =  0.85). The systematic 
underestimation of the AD factor by 10-20 % in EB/PF-C6fl 
systems may be considered acceptable, given the absence 
of any adjustable parameters in the analysis and difficulty 
in estimating the real values of the concentrations and com­
plexation constants in the intracellular environment. How­
ever, we consider that the most important result here is 
actually not the degree of the coincidence between the the­
oretical and experimental curves, but the fact that using the 
sole assumption of hetero-association as the major operat­
ing process, and using just the hetero-association constants 
and the concentrations of C6fl fullerene, it has become pos­
sible to predict a similar order of magnitude effect of recov­
ery of the functional activity of the cell nucleus compared 
to that observed in the experiment.
Consequently, it can be argued that the initial working 
hypothesis should be valid, i.e., that the interceptor mech­
anism (i.e., drug-fullerene hetero-association) plays the
Concentration o f  CgQ fullerene, mM
Concentration of C§o fullerene, mM
Concentration ofCgo fullerene, mM
Fig. 5 The Ad factor in drug-fullerene systems as a function 
of C60 fullerene concentration [experimental AD factor for three 
donors (dots)]; theoretical AD factor [solid сште DOX-C60 fuller­
ene: Kb =  61.9 103 M _1 (Evstigneev et al. 2013); EB-C60
fullerene: Kb =  44 :■: 103 (see the text); PF-C60 fullerene: 
Kb =  26.1 103 M _1 (Evstigneev et al. 2013)]
dominant role in the observed effects of the action of aro­
matic BACs on human buccal epithelial cells in the pres­
ence of C6fl fullerene. This statement does not, however, 
exclude the contribution from other possible mechanisms 
not discussed in this article, but their role appears to be of 
minor importance.
The formulated conclusions about the dominant role of 
the interceptor mechanism are the main outcome of the 
present work supporting the view that in the observed case 
of regulation of the in vitro biological activity of aromatic 
compounds in the presence of C6fl fullerene, the key role 
is played by the physico-chemical parameters of the non- 
covalent interaction between the drug and C6fl fullerene. In 
fact, the knowledge of the equilibrium constants of the het- 
ero-association of C6fl fullerene with different BACs meas­
ured in a simple physico-chemical experiment enables us to 
predict the effect of C6fl fullerene on the biological activity 
of aromatic drugs in vitro. Let us further discuss these find­
ings against the extensively investigated combinations of 
aromatic BACs with xanthine interceptor molecules avail­
able in the literature to date.
Effect of the drugs in the presence of CAF
As mentioned above, the concept of interceptor action was 
previously successfully applied with respect to drug-xan- 
thine combinations in various proliferating cell systems, of 
which the largest volume of published materials relates to 
the typical xanthine molecule, CAF [see (Evstigneev 2013; 
Woziwodzka et al. 2013) for reviews]. Keeping in mind that 
hetero-association is a molecular process not depending 
on the type of cell system and assuming that the intercep­
tor mechanism actually dominates in the observed in vitro 
biological effects in the drug-fullerene systems studied, we 
can expect to observe a similar biological response (repre­
sented by similar changes in HGQ and ENN parameters) in 
the drag-C6fl fullerene and drug-CAF systems for the same 
set of drugs, provided that other experimental conditions 
are kept identical. In the present work, this hypothesis was 
tested in the study of the combined action of the drug-CAF 
systems in buccal epithelial cells.
Analysis of the HGQ, ENN and PSC parameters under 
the individual action of CAF in the absence of drugs (see 
Fig. 3 and Supplementary material) demonstrates no sta­
tistically significant relationship with the exposure time 
varying from 10 min to 3 h and concentrations reaching a 
millimolar range. Consequently, within the limitations of 
the methods used, CAF itself does not exert a pronounced 
effect on the functional state of buccal epithelial cells, 
which is similar to the report above for C6fl fullerene. This 
allows evaluation of the action of the drug-CAF combina­
tions to be carried out based on analysis of HGQ and ENN
Table 2 Theoretical and experimental AD factors in drug-CAF systems
ADexp ADtheor (interceptor and ADtheor (interceptor
----------------------------------------------------------------------------------- protector mechanisms) mechanism only)
Donor A Donor В Donor С
DOX-CAF 0.89 ± 0 .1 7  0.85 ± 0 .1 1  0.62 ± 0 .1 1  0.35 0.18
EB-CAF 0.63 ±  0.15 0.58 ± 0 .0 9  -  0.46 0.14
PF-CAF 0.86 ± 0 .1 7  0.59 ± 0 .1 4  0.55 ± 0 .1 3  0.71 0.44
changes assuming that the changes are only caused by the 
drug.
The published data indicate that the effects of intercep­
tor action of CAF toward the studied drugs DOX/PF/EB 
are the most pronounced at the millimolar concentrations 
of the interceptor molecules (Evstigneev 2013; Traga­
nos et al. 1991). It should also be noted that in case of the 
drug-CAF systems, the protector mechanism may also be 
involved (Buchelnikov et al. 2012; Evstigneev et al. 2006, 
2008, 2011; Evstigneev 2013); however, its actual role and 
significance have still not been fully investigated (Goluriski 
et al. 2013; Buchelnikov et al. 2012). Table 2 lists the val­
ues of the Ad factors, calculated for the maximal concentra­
tion of CAF used in the work (yfl ~  5 mM), i.e., the experi­
mental one [re-calculated from the measured values of 
the HGQ parameter using Eq. (4)] and the theoretical one 
(calculated from the solution of the full system of equa­
tions from the theory of interceptor/protector action (Evs­
tigneev et al. 2008), which takes the protector mechanism 
into account). There is a satisfactory agreement between 
the theoretical predictions and experimental results. It is 
also seen that exclusion of the protector mechanism for 
CAF worsens the quality of agreement between the theory 
and the experiment, as might be expected. Hence, the ini­
tial hypothesis about the dominance of the interceptor and 
protector mechanisms in nonproliferating human buccal 
epithelial cells under the action of drug-CAF combinations 
appears to be valid and provides an additional support to 
the above-formulated conclusion on the interceptor mecha­
nism of action of C6fl fullerene on the in vitro biological 
activity of aromatic compounds.
Conclusion
In the present work, a concentration-dependent restora­
tion of the non-disturbed biological state of the living cell 
exposed to various aromatic compounds was observed on 
addition of pristine C6fl fullerenes by means of assessment 
of the heterochromatin structure in the cell nucleus and bar­
rier function of the cell membrane and the method of cell 
microelectrophoresis in buccal epithelial cells. The optimal 
conditions for the observation of this effect, i.e., exposure 
time and concentrations of the drugs, were established. The
experimental dependence of the number of heterochroma­
tin granules on the concentration of C6fl fullerene for all 
donors in the drug-C6fl systems tested has been sufficiently 
well described within the framework of the theory of inter­
ceptor/protector action (Buchelnikov et al. 2012; Evs­
tigneev et al. 2006, 2008, 2011; Evstigneev 2010), which 
assumes the dominance of the so-called interceptor mecha­
nism, i.e., non-covalent complexation (hetero-association) 
of the drug with C6fl fullerene leading to the observed bio­
logical effects. An independent verification of the results 
was carried out against the drug-caffeine systems, most of 
which are well described in the literature within the frame­
work of the interceptor/protector action.
In summary, the obtained data indicate the existence 
of a molecular process (i.e., hetero-association) that does 
not depend on the type of cell culture used and modulates 
the in vitro biological effects of the aromatic drugs in the 
presence of C6fl fullerene as the interceptor molecule. This 
result is important in the context of the potential use of 
pristine C6fl fullerene together with the aromatic antitumor 
drugs in combination anticancer therapy.
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